Open Nav
Participating Investors

Below is a representative list of participating investors for the 2019 CEO & Investor Conference:

3E Bioventures
Accelerator Life Science Partners
Aceras BioMedical
Acorn Asset Advisors
Actinium Capital
Acuris Partners
Adjuvant Capital
AE Capital 
Aegis Capital Corp.
Affinity Asset Advisors
Agent Capital
AIG Global Investment Corporation
Aisling Capital
Aleph Capital
Alexandria Capital
Alignment Ventures
Alliance Global Partners
Alpha BioLabs
Alpha Blue Ocean Advisors 
Alpha Holdings
Amzak Health
Andreessen Horowitz
Aperture Venture Partners
Apotheosis Ventures
Aracle Capital
Arch Venture Partners
Arcus Ventures
Aristar Capital
Arix Bioscience
Arsenal Capital Partners
Ashford Capital Management
Aspire Capital
Asset Management Ventures
Astute Capital
ATEL Ventures Inc
Athena Bio Ventures
Atheneos Ventures
Athyrium Capital Management
Aurora Capital, LLC
B. Riley FBR
Band of Angels
Bank of America Merrill Lynch Global Research
BE Capital
Beacon Capital
Berenberg Capital Markets
BHP Capital
BIMA Capital
Bioadvance-The Biotech Greenhouse Corp of Southeas
BioInnovation Capital
Biomark Capital
Biondo Investment Advisors
BioSense Global
Biotech Alliances International
Bioventure Partners
Black Diamond Advisors 
Bloom Capital
BMO Capital Markets (U.S.)
BOHE Angel Fund
Bojian Capital
Borex Capital
Bridge Bank
Brio Capital Management
Brock Capital Group
Brookline Capital Markets
Brothers & Partners Europe
Bryan, Garnier & Co
Capgenic Advisors
Cato BioVentures
Caxton Alternative Management 
CB1 Capital
C-Bridge Capital
CEC Capital Group
Cedrus Investments
Chardan Capital Markets
Charlestown Capital
Checkmate Capital
China Grand
Chronon Capital
CJ Seligman & Co.
Connectivity Ventures
Cowen and Company
Cowen Healthcare Investments
Cowin Capital
Crown Point Group
CS McKee
CSC Leasing
CTI Life Sciences
CTTQ Phamaceutical Group
Dabar Investment Associates
Danish Consulate
Dec Family Ventures
Deca Ventures
Delos Capital Partners/Delos Life Sciences
Deltec Bank
Delwar Capital Management 
Diamondback Capital Management
District 2 Capital
Douglas C. Lane & Associates
Dynamk Capital
E Squared Capital Management, LLC
Easton Capital
Efrat Investments
Ensconce Capital
Entech Bio
Esousa Holdings
Everpine Capital
EVOLUTION Life Science Partners
Exar North Partners
Excelyrate Capital
Fannin Innovation Studio
FC Capital Management
Fiera Capital
First Island Capital
Foresite Capital Management
Fortress Biotech
Fortunatus Capital
Fosun Pharma
Fountain Healthcare Partners
Foxhill Asset Management
GCF Family Office
GE Ventures
Genoa Ventures
GHS Investments
Global Corporate Finance
Global Health Investment Fund
Global Source Ventures
Golden Seeds
Goldwater Asset Management
Good Health Capital
Gorlin Companies
Gradus/ RSJ Private Equity
GreenSky Capital
Grey Sky Venture Partners
Griffin Securities
H.C. Wainwright & Company
H.I.G. BioHealth Partners
H.I.G. Capital
Harbin Pharmaceutial Group
Harborview Capital
Hartford Financial Mgmt
Hayfin Capital Management
HealthCare Royalty Partners
Helicase Venture
Helix Management
Hemi Ventures
Hercules Capital
HI Investors Capital
HighCape Capital
Hood River Capital Management
Horizon Technology Finance
Hudson East Capital
Humanwell Healthcare Group
Iaso Ventures
IDG Capital Partners
Illumina Ventures
Image Analysis Group
INKEF Capital
InMed Pharmaceuticals
Jafco Co.
Janney Montgomery Scott
JBS Healthcare Ventures
Jina Ventures
Johnston Associates
JP Morgan
K2 HealthVentures
Kalka Fund LP
Katalyst Securities
KESA Partners
Knoll Capital Management
Krensavage Asset Management 
L1 Capital
L2 Capital
Ladenburg Thalmann
Laidlaw & Company
Landmark Angels
Leaf Capital Partners

Legal & General Investment Management
LifeScience EquityPartners
LifeTech Capital
Lilly Asia Ventures
Lincoln Park Capital
Locust Walk
Longitude Capital
Lord Abbett
Lumira Capital
Madison Square Capital
Magid Family Office
Manatuck Hill Partners
Maxim Group
Maxim Merchant Capital
MayTech Global Investments
MAZ Capital Advisors
Medexplore Ventures
Medstartr Ventures
MEDX Ventures Group
Merlin Nexus
Mid Atlantic Bio Angels
Militia Hill Ventures
Mithril Capital Management
Mitsui & Co. Global Investment
Mizuho Bank
Mizuho Securities
Momentum Biotech
Mont Blanc Capital Partners
Montrose Capital Partners
Moose Hill Asset Management 
Mossrock Capital
MP Healthcare Venture Management
MPM Capital
MSAB Capital
MSQ Ventures
Muirfield Capital.
Murdock Capital Partners Corporation
MV Corp Services
MVP Capital Partners
National Securities Corporation
NauVista Capital Management
NCL Technology Ventures
Needham & Company
New Harbor Venture Partners
New Science Ventures
New York City Economic Development Corporation
Newburgh Bay Capital
Nexus Medical and Technology Capital
NGN Capital
Noble Capital Markets
Noble Equity Fund
Noble Life Science Partners
Nordcon Capital
Northern Light Venture Capital
Novatio Ventures
NYC Medtech/Perselson
NYU Innovation Venture Fund
Oberland Capital Management
Olive Tree Capital
Oncolytics Biotech
Oppenheimer & Co
Opti Capital Management
Orange Grove Bio
OrbiMed Advisors 
Orchard View Capital Advisors 
Orion Consultoria Financeira
Otsuka Pharmaceutical Co.
Oxford Finance
Pappas Capital
Park Ave. Capital Management International
Paulson Investment Company
Peak One Investments
Peter B. Cannell & Co.
Petrichor Healthcare Capital Management
Pharmakon Advisors
Pipeline Angels
Pipeline Capital
Piper Jaffray Ventures
Portola Capital Partners
Powder Gate
Prevail Partners
Princeton Biopharma
Promethean Capital Group
Qiming Venture Partners
Quan Capital
Radius Financial
RBC Capital Markets Wealth Management
RBV Capital
Red Hook Asset Management
Remsen Investors LP
Repertoire Asset Management
RHK Capital
Rockefeller & Co.
ROTH Capital Partners - Analysts
Royalty Pharma Management
RTP Capital
Sabby Management
Santen Pharmaceutical Co.
Sarasota Investments
Satter Medical Technology Partnership
SBP Management
SC Fundamental
Scopus Ventures
Seaside 88 Capital
Second Line Capital Mgmt
Seroba Life Sciences
Serrado Capital
Shanghai Fosun Pharmaceutical (Group) Co.
Shaw Strategic Capital
Shenzhen Salubris Pharmaceuticals Co.
Shenzhen Yuankang Investment Management
Simran Investment
Simrx Advisors
Sio Capital Management
Slater Technology Fund
Sofinnova Ventures
Sorrento Therapeutics
Special Situations Funds
SPRIM Ventures
Square 1 Bank
Stadnyk and Partners
StarLink Capital
SternAegis Ventures
Sun Pharmaceuticals
SunTrust Robinson Humphrey
Surveyor Capital
SV Investment
Symphonia Partners
Syno Capital
Taglich Private Equity
Talfinium Investments
Tanaka Capital Management
Tap Advisors
Terra Magnum Capital Partners
The Anson Group
The Astrologers Fund
The Carlyle Group
The Engine
The Leukemia & Lymphoma  Society
The Lind Partners
The Mark Foundation for Cancer Research
TransPacific Venture Capital Partners
Trevie Capital
Triple Gate Capital
Tryphon Capital Advisors
Turret Capital Mangement
Unum Capital
Upstream Partners
Uptick Capital 
V2m Life Sciences Fund
Vector Capital 
Vector Resource Funds
Versant Ventures
Vida Ventures
Viva Biotech Holdings
Vivo Capital
W Global Capital /International Capital Management
Wallachbeth Capital
Watermill Asset Management
WBB Asset Management
WBB Securities, LLC
Wells Fargo
WestPark Capital
Wexford Capital
Whitwell Partners
William Blair
Wolf Capital Management
Wolpert Associates
Xeraya Capital Life Venture
XOMA Corporation
YA Global
Yale University
YlLGA Management Services
Yonjin Capital
Young America Capital
Yuhan USA
Zacks SCR
Zeniths Capital
Zenity Holdings New York

*as of 2/6/2019